Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon Gamma
- 4 January 1990
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (1), 16-21
- https://doi.org/10.1056/nejm199001043220104
Abstract
Acute visceral leishmaniasis is associated with an antigen-specific immunosuppression of mononuclear cells as evidenced by defective in vitro production of interferon gamma. We evaluated treatment with recombinant human interferon gamma in combination with conventional pentavalent antimony therapy in patients with visceral leishmaniasis.Keywords
This publication has 19 references indexed in Scilit:
- Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon GammaNew England Journal of Medicine, 1988
- Immunochemotherapy for Intracellular Leishmania donovani Infection: Interferon Plus Pentavalent AntimonyThe Journal of Infectious Diseases, 1988
- New Perspectives on a Subclinical Form of Visceral LeishmaniasisThe Journal of Infectious Diseases, 1986
- Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous LeprosyNew England Journal of Medicine, 1986
- Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.JCI Insight, 1985
- Response of resting human peripheral blood natural killer cells to interleukin 2.The Journal of Experimental Medicine, 1984
- Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.The Journal of Experimental Medicine, 1984
- Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.JCI Insight, 1983
- Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.The Journal of Experimental Medicine, 1982
- Gaps in Therapy for Infectious Diseases: Conference SummaryThe Journal of Infectious Diseases, 1982